Patent details

EP1620133 Title: GENE THERAPY FOR NEUROMETABOLIC DISORDERS

Basic Information

Publication number:
EP1620133
PCT Application Number:
PCT/US/2004/013685
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047606942
PCT Publication Number:
WO/2004/098648
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GENE THERAPY FOR NEUROMETABOLIC DISORDERS
French Title of Invention:
THERAPIE GENIQUE POUR TROUBLES NEUROMETABOLIQUES
German Title of Invention:
GENETHERAPIE FÜR NEURO-STOFFWECHSEL KRANKHEITEN
SPC Number:

Dates

Filing date:
30/04/2004
Grant date:
09/12/2015
EP Publication Date:
09/12/2015
PCT Publication Date:
18/11/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/02/2006
EP B1 Publication Date:
09/12/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/04/2019
Expiration date:
30/04/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/04/2004
 
 

Name:
GENZYME CORPORATION
Address:
500 Kendall Street, Cambridge, MA 02142, United States (US)

Agent

Name:
ARONOVA S.A.
From:
09/02/2016
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
STEWART Gregory R.
Address:
United States (US)

2

Name:
DODGE James
Address:
United States (US)

3

Name:
PASSINI Marco, A.
Address:
United States (US)

Priority

1

Priority Number:
467195 P
Priority Date:
01/05/2003
Priority Country:
United States (US)

2

Priority Number:
475726 P
Priority Date:
04/06/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 48/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
11/04/2018
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages